ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.
… Head of Clinical Quantitative Science ProQR Therapeutics is a … focusing on biostatistics and data science to drive trial design and strategic decision-making. Design and … models ) to enhance the efficiency and scientific rigor of clinical trials. Analyze opportunities through disease …
Featuring Dr. Byron Lam, Professor, Bascom Palmer Eye Institute, University of Miami School of Medicine
Hosted by Cantor Biotechnology Analysts Emma Nealon, Alethia Young